Solstice Capital logo

Solstice Capital

North America, Massachusetts, United States, Salem

Description

Solstice Capital is a seasoned early-stage venture capital firm with a long-standing presence in the investment landscape, having been founded in 1997. The firm is dedicated to identifying and supporting promising seed and early-stage companies, aligning with its stated goal of generating superior venture capital returns for its limited partners. While the provided information specified "Salem" as its location, the firm widely recognized for its venture capital activities matching this description operates out of Tucson, Arizona.

The firm's investment thesis centers on disruptive technologies and innovative business models across a range of high-growth sectors. Solstice Capital primarily targets opportunities within software, internet, mobile, e-commerce, fintech, healthcare IT, and SaaS. Geographically, while it has a strong presence and focus on the Southwest United States, including Arizona, California, Texas, and Colorado, its investment reach extends to companies across the nation.

Solstice Capital typically deploys initial checks ranging from $500,000 to $3 million, making it a key partner for companies in their formative stages. The firm has demonstrated consistent fundraising success, notably closing its Fund V in 2018 with $100 million in committed capital, underscoring its continued capacity for investment. With a track record spanning over two decades, Solstice Capital has made more than 100 investments and facilitated over 20 exits, showcasing its ability to identify and nurture successful ventures. The firm prides itself on not just providing capital, but also offering strategic guidance and operational support to its portfolio companies, leveraging its extensive network and experience to help founders scale their businesses.

Investor Profile

Solstice Capital has backed more than 44 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 5% of its total and boasts 17 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Software, Health Care.
  • Typical check size: $500K – $3M.

Stage Focus

  • Series B (32%)
  • Series C (23%)
  • Series Unknown (20%)
  • Series A (20%)
  • Series D (5%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Software
  • Health Care
  • Manufacturing
  • Medical
  • Electronics
  • Therapeutics
  • Genetics
  • Health Diagnostics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Solstice Capital frequently co-invest with?

Village Ventures
North America, Massachusetts, United States, Williamstown
Co-Investments: 7
Sevin Rosen Funds
North America, Texas, United States, Dallas
Co-Investments: 4
BI
North America, California, United States, Pebble Beach
Co-Investments: 3
Grayhawk Capital
North America, Arizona, United States, Scottsdale
Co-Investments: 3
Highway 12 Ventures
North America, Idaho, United States, Boise
Co-Investments: 3
Commons Capital
North America, Massachusetts, United States, Brookline
Co-Investments: 4
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 3
CB Health Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 3
Valley Ventures
North America, Arizona, United States, Phoenix
Co-Investments: 12
Toppan Printing
Asia, Tokyo, Japan, Tokyo
Co-Investments: 3

Which angels does Solstice Capital often collaborate with?

AW
North America, Massachusetts, United States, Acton
Shared Deals: 1

What are some of recent deals done by Solstice Capital?

HTG Molecular Diagnostics

Tucson, Arizona, United States

HTG Molecular Diagnostics develops assays and reagent systems for gene expression analysis.

BiotechnologyGeneticsHealth DiagnosticsLife ScienceMedical
Series DJun 13, 2011
Amount Raised: $16,200,000
Regenesis Biomedical

Scottsdale, Arizona, United States

Regenesis Biomedical focuses on the development of non-invasive regenerative medicine products.

BiotechnologyHealth CareMedical DeviceWellness
Series CJun 6, 2011
Amount Raised: $5,300,000
HTG Molecular Diagnostics

Tucson, Arizona, United States

HTG Molecular Diagnostics develops assays and reagent systems for gene expression analysis.

BiotechnologyGeneticsHealth DiagnosticsLife ScienceMedical
Series CNov 28, 2008
Amount Raised: $2,800,000
CodeRyte

Bethesda, Maryland, United States

CodeRyte is a provider of computer-assisted coding and clinical data extraction solutions for the healthcare industry.

Health CareMedicalNatural Language ProcessingSoftware
Series DNov 14, 2008
Amount Raised: $13,000,000
Regenesis Biomedical

Scottsdale, Arizona, United States

Regenesis Biomedical focuses on the development of non-invasive regenerative medicine products.

BiotechnologyHealth CareMedical DeviceWellness
Series BMay 22, 2008
Amount Raised: $2,787,000
Lumidigm

Albuquerque, New Mexico, United States

Lumidigm provides biometric identity management solutions for point-of-sale (POS), civil ID and portable electronic device applications.

BiometricsIdentity ManagementNetwork SecurityPoint of Sale
Series CJan 29, 2008
Amount Raised: $7,000,000
AmpliMed Corporation

Tucson, Arizona, United States

AmpliMed Corporation offers small molecule drugs for the treatment of cancer in the pancreas, ovaries and lungs.

BiotechnologyHealth CareTherapeutics
Series CJan 14, 2008
Amount Raised: $5,000,000
HTG Molecular Diagnostics

Tucson, Arizona, United States

HTG Molecular Diagnostics develops assays and reagent systems for gene expression analysis.

BiotechnologyGeneticsHealth DiagnosticsLife ScienceMedical
Series COct 8, 2007
Amount Raised: $5,619,000
Arxan Technologies

San Francisco, California, United States

Arxan is the trusted global leader of application protection and management products for IoT, Mobile, and other applications.

AnalyticsCyber SecurityInternet of ThingsMobile AppsProfessional ServicesSecuritySoftware
Series CMar 5, 2007
Amount Raised: $13,000,000
Regenesis Biomedical

Scottsdale, Arizona, United States

Regenesis Biomedical focuses on the development of non-invasive regenerative medicine products.

BiotechnologyHealth CareMedical DeviceWellness
Series BAug 21, 2006
Amount Raised: $527,000